Trial Profile
A phase II/III study of SHP-609 for the treatment of Hunter Syndrome
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 05 Feb 2020
Price :
$35
*
At a glance
- Drugs Idursulfase (Primary)
- Indications Mucopolysaccharidosis II
- Focus Therapeutic Use
- 17 Dec 2015 New trial record
- 15 Dec 2015 According to a Shire media release, Shire plans to initiate this study in 2016.